Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients
Marina de Tommaso, Marianna La Rocca, Silvia Giovanna Quitadamo, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Mode and site of action of therapies targeting CGRP signaling
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Is there a role of calcitonin gene-related peptide in cortical spreading depression mechanisms?– Argument pro
Marina Romozzi, Paolo Calabresi
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Migraine Treatment: Towards New Pharmacological Targets
Marcello Silvestro, Luigi Francesco Iannone, Ilaria Orologio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12268-12268
Open Access | Times Cited: 16
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study
Alicia Alpuente, Anna de la Torre-Suñe, Edoardo Caronna, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 13
Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
fNIRS as a biomarker for X-linked neurodevelopmental disorders: leveraging visual processing to assess brain function?
Elena Scaffei, Chiara Bosetti, Roberta Battini, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Journal of Neurology (2023) Vol. 270, Iss. 11, pp. 5600-5612
Open Access | Times Cited: 5
Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients
Marianna La Rocca, Anna Laporta, Livio Clemente, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 4
Resting‐state electroencephalography microstate dynamics altered in patients with migraine with and without aura—A pilot study
Xiangyu Lei, Meng Wei, Liang Wang, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 8, pp. 1087-1096
Open Access | Times Cited: 4
Exploring Aesthetic Perception in Impaired Aging: A Multimodal Brain—Computer Interface Study
Livio Clemente, Marianna La Rocca, Giulia Paparella, et al.
Sensors (2024) Vol. 24, Iss. 7, pp. 2329-2329
Open Access
EEG Changes in Migraine—Can EEG Help to Monitor Attack Susceptibility?
Thomas C. van den Hoek, Mark van de Ruit, Gisela M. Terwindt, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 508-508
Open Access
Anticuerpos monoclonales anti-PRGC y modificación de la historia natural de la migraña
Mariano Huerta Villanueva, Sergio Campoy Díaz, Albert Muñoz‐Vendrell
Kranion (2022) Vol. 17, Iss. 4
Open Access
Page 1

Scroll to top